Aidoc
PrivateLast Round
Series E
Apr 29, 2026
Est. Valuation
$1.2B
Total Funding Raised
$530M
Momentum
Top 5%
of companies Caplight tracks
Company Overview
Aidoc is a healthcare technology company that develops AI-powered solutions for medical imaging analysis to assist physicians in detecting and triaging acute abnormalities.
Sector
Healthcare & Life Sciences
Verticals
Medical Imaging, Medical AI, Healthcare Analytics, Computer Vision
Business Model
B2B
Customer Profile
Subscription SaaS, Usage-Based SaaS
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Aidoc Comparables
Compare Aidoc with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Viz.ai | 87% | |
| Harrison.ai | 85% | |
| Avicenna.AI | 85% |
For institutional investors. Book with your work email.
Aidoc Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series E | Apr 29, 2026 | ||||
| Debt | Jul 23, 2025 | ||||
| Growth Equity | Jul 23, 2025 | ||||
| Strategic | Jan 21, 2025 | ||||
| Series D | Jun 16, 2022 | ||||
Series C | Jul 13, 2021 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Aidoc Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| SoftBank Investment Advisers | Series E |
| TCV | Growth Equity, Series D |
| Jibe Ventures | Growth Equity, Series C |
| Synetro Group | Series C |
| Magma Venture Partners | Series C, Series A, Series B, Series D, Growth Equity, Series E |
| SoftBank Group | Series E |
| NVentures | Growth Equity, Series E |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Oct 20, 2026
AI-drafted radiology reports product FirstRead completes successful beta.
- Oct 13, 2026
Adheres to IEC 62366 standard for usability engineering.
For institutional investors. Book with your work email.
Recent news
Latest coverage and updates
- launchesNov 2, 2026
Aidoc launches AI on the Front Lines, a podcast about real-world decisions behind clinical AI, hosted by Dr. Jesse Ehrenfeld, on Nov 2nd '26.
- recognized_asNov 1, 2026
TIME magazine names Aidoc's CARE artificial intelligence model, CARE, one of its Best Inventions of 2026 in the Medicine and Health category on Nov 1st '26.
- is_developingSep 23, 2026
In Sep '26, Aidoc continues to develop new radiology workflow solutions on CARE with safety, quality, and accuracy in mind.
- partners_withAug 16, 2026
In 2024, Aidoc partners with Riverain Technologies to deploy a solution for lung nodule detection and measurement, adding support for radiologists reviewing chest CT scans in New Zealand.
- is_developingAug 16, 2026
Aidoc is developing First Read for Chest X-ray in advanced stages as a radiology reporting solution that analyzes chest X-rays across broad findings and generates preliminary report drafts, with regulatory clearance still pending and radiologists retaining review and final sign-off control.
For institutional investors. Book with your work email.
Aidoc Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Aidoc's valuation, stock price, and market status.
Is Aidoc a public or private company?
Aidoc is a private company.
What is the current stock price of Aidoc?
Aidoc is a private company, so its shares have no public market price. Caplight tracks Aidoc's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Aidoc worth (valuation)?
Aidoc's valuation is estimated at $1.2B based on funding round data.
Can I buy Aidoc stock?
Aidoc shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Aidoc's last funding round?
Aidoc's most recent funding round was Series E on April 29, 2026.
Who are the main investors in Aidoc?
Key investors in Aidoc include TCV, Alpha Intelligence Capital, TCV, TLV Partners, General Catalyst.
Will Aidoc IPO soon?
No public IPO plans have been announced for Aidoc.
How can I track Aidoc secondary market activity?
Caplight tracks bids, offers, and trades in Aidoc's shares on secondary markets.